(Q34219598)

31 July 2017

Is statin-associated cognitive impairment clinically relevant? A narrative review and clinical recommendations (English)

1 reference

31 July 2017

cognitive dysfunction

1 reference

based on heuristic

inferred from title

author name string

Carlos H Rojas-Fernandez

series ordinal

1

1 reference

PubMed ID

22474137

31 July 2017

Jean-Christy F Cameron

series ordinal

2

1 reference

PubMed ID

22474137

31 July 2017

language of work or name

English

0 references

publication date

3 April 2012

1 reference

Annals of Pharmacotherapy

31 July 2017

1 reference

31 July 2017

46

1 reference

31 July 2017

4

1 reference

31 July 2017

549-557

1 reference

Randomized clinical trials and recent patterns in the use of statins.

31 July 2017

1 reference

2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult - 2009 recommendations

21 January 2018

1 reference

The safety of statins in clinical practice

21 January 2018

1 reference

Behavioral changes with paranoia in an elderly woman taking atorvastatin

21 January 2018

1 reference

Short-term memory loss associated with rosuvastatin.

21 January 2018

1 reference

Simvastatin-induced decline in cognition.

21 January 2018

1 reference

Cognitive impairment associated with atorvastatin and simvastatin

21 January 2018

1 reference

Simvastatin-associated memory loss

21 January 2018

1 reference

Statin-associated memory loss: analysis of 60 case reports and review of the literature

21 January 2018

1 reference

Atorvastatin and pitavastatin improve cognitive function and reduce senile plaque and phosphorylated tau in aged APP mice.

21 January 2018

1 reference

Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors.

21 January 2018

1 reference

Statins and the risk of dementia

21 January 2018

1 reference

Use of lipid-lowering agents, indication bias, and the risk of dementia in community-dwelling elderly people.

21 January 2018

1 reference

Do cholesterol-lowering agents affect brain activity? A comparison of simvastatin, pravastatin, and placebo in healthy volunteers

21 January 2018

1 reference

Central nervous system effects of HMG CoA reductase inhibitors: lovastatin and pravastatin on sleep and cognitive performance in patients with hypercholesterolemia.

21 January 2018

1 reference

Effects of treatment with simvastatin and pravastatin on cognitive function in patients with hypercholesterolaemia

21 January 2018

1 reference

Effect of pharmacologic lipid lowering on health-related quality of life in older persons: results from the Cholesterol Reduction in Seniors Program (CRISP) Pilot Study.

21 January 2018

1 reference

Peripheral arterial disease: morbidity and mortality implications

21 January 2018

1 reference

Effect of atorvastatin on cognitive function in patients from the Lipid Lowering and Onset of Renal Disease (LORD) trial.

21 January 2018

1 reference

Randomized trial of the effects of simvastatin on cognitive functioning in hypercholesterolemic adults

21 January 2018

1 reference

Effects of lovastatin on cognitive function and psychological well-being

21 January 2018

1 reference

Effects of treatment with lovastatin and pravastatin on daytime cognitive performance.

21 January 2018

1 reference

Effects of atorvastatin on higher functions

21 January 2018

1 reference

Atorvastatin, diabetic dyslipidemia, and cognitive functioning

21 January 2018

1 reference

Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial

21 January 2018

1 reference

Pravastatin and cognitive function in the elderly. Results of the PROSPER study

21 January 2018

1 reference

Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions

21 January 2018

1 reference

The impact of the use of statins on the prevalence of dementia and the progression of cognitive impairment.

21 January 2018

1 reference

Serum lipoprotein levels, statin use, and cognitive function in older women

21 January 2018

1 reference

Life long changes in cognitive ability are associated with prescribed medications in old age.

21 January 2018

1 reference

Statins and cognitive functioning in the elderly: a population-based study

21 January 2018

1 reference

Delirium after elective surgery among elderly patients taking statins

21 January 2018

1 reference

The association of statin use and statin type and cognitive performance: analysis of the reasons for geographic and racial differences in stroke (REGARDS) study

21 January 2018

1 reference

Statin-associated adverse cognitive effects: survey results from 171 patients.

21 January 2018

1 reference

Users' guides to the medical literature. IV. How to use an article about harm. Evidence-Based Medicine Working Group

21 January 2018

1 reference

Conceptual foundations of the UCSD Statin Study: a randomized controlled trial assessing the impact of statins on cognition, behavior, and biochemistry

21 January 2018

1 reference

Cholesterol and myelin biogenesis

21 January 2018

1 reference

Statin therapy inhibits remyelination in the central nervous system.

21 January 2018

1 reference

Negative impact of statins on oligodendrocytes and myelin formation in vitro and in vivo.

21 January 2018

1 reference

The clinical use of HMG CoA-reductase inhibitors and the associated depletion of coenzyme Q10. A review of animal and human publications

21 January 2018

1 reference

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

21 January 2018

1 reference

Linking lipids to Alzheimer's disease: cholesterol and beyond

21 January 2018

1 reference

Vascular effects of HMG CoA-reductase inhibitors (statins) unrelated to cholesterol lowering: new concepts for cardiovascular disease.

21 January 2018

1 reference

An assessment of statin safety by neurologists.

21 January 2018

1 reference

There is no evidence for an increase in acute coronary syndromes after short-term abrupt discontinuation of statins in stable cardiac patients

21 January 2018

1 reference

Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.1Q620

1 reference

31 July 2017

1 reference

PubMed ID

22474137